What We Do

New Amsterdam Sciences develops novel, safe and effective therapies for persistent inflammatory conditions, with an initial focus on Pulmonary Fibrosis and CNS Disorders.

Idiopathic Pulmonary Fibrosis

Developing and delivering candidates which safely and effectively treat orphan lung diseases.
Learn More

Progressive Supranuclear Palsy

Developing first-in-line therapies for orphan neurodegenerative disorders like Progressive Supranuclear Palsy (PSP).
Learn More

Influenza

Developing targeted therapies and adjuvants for influenza which have demonstrated greater efficacy than Tamiflu, the current “gold standard.”
Learn More

Radiomitigators

Developing radiation mitigators to treat the difficult side effects that can occur from undergoing radiation therapy for cancer, as well as biodefense applications.
Learn More

Narrow focus, open minds

NAS pursues novel treatments to enhance the lives of patients in multiple areas of development in order to yield more opportunities.
Other Areas of Interest

Invest

Invest

New Amsterdam Sciences invites you to join in the fight to save countless lives and breathe life into the development of a new and exciting therapeutic! Contact us, be a part of our movement, help save a life and learn more about our investment opportunities now!

© 2020 New Amsterdam Sciences | Terms of Use | Privacy PolicyContact Us